Peter Horby

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Boghog (talk | contribs) at 06:18, 7 September 2020 (added missing details to cite). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jump to navigation Jump to search

Peter Horby is a British medical doctor, epidemiologist, and Professor of Emerging Infectious Diseases and Global Health at the University of Oxford and Chair of the UK government's New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). He is the founder, and former Director of the Oxford University Clinical Research Unit in Hanoi, Vietnam which was founded in 2006. In 2014 Peter established the Epidemic Research Group Oxford (ERGO). ERGO incorporates a number of international projects such as the European Commission funded PREPARE and the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). In 2016 Peter became Chair of ISARIC

Horby specialises in the design of control programmes against infectious diseases. He is now heading up the major RECOVERY Trial into drugs for COVID-19.[1] On 16 June 2020, he gave a statement at 10 Downing Street alongside the Prime Minister and Chief Scientific Adviser announcing the first positive trial results of the first life-saving COVID-19 drug, Dexamethasone.[2][3] He is the primary author on the published preliminary report.[4]

Horby is one of the 23 attendees of the Scientific Advisory Group for Emergencies (SAGE) [5] He is the Chair of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG).[6][5]

References

  1. ^ "ISRCTN - ISRCTN50189673: A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus)". www.isrctn.com. Retrieved 2020-09-06.
  2. ^ "Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 | University of Oxford". www.ox.ac.uk. Retrieved 2020-09-06.
  3. ^ "Prime Minister's statement on coronavirus (COVID-19): 16 June 2020". GOV.UK. Retrieved 2020-09-06.
  4. ^ Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. (July 2020). "Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report". The New England Journal of Medicine. 0 (0): null. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530.
  5. ^ a b Sample, Ian (24 April 2020). "Who's who on secret scientific group advising UK government?". The Guardian. Retrieved 24 April 2020.
  6. ^ "New and Emerging Respiratory Virus Threats Advisory Group". gov.uk. Retrieved 24 April 2020.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Peter_Horby&oldid=977152733"